These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1024 related articles for article (PubMed ID: 9820470)

  • 21. [Chronic kidney disease, too often, too late].
    Lang P
    Presse Med; 2006 Jan; 35(1 Pt 1):9-10. PubMed ID: 16462655
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk factors for cardiovascular disease in children on maintenance dialysis.
    Chavers B; Schnaper HW
    Adv Ren Replace Ther; 2001 Jul; 8(3):180-90. PubMed ID: 11533919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reverse epidemiology in hemodialysis patients. Lessons from Japanese registries.
    Shoji T; Tsubakihara Y; Nakai S; Nishizawa Y
    Nephrol Ther; 2008 Jul; 4(4):223-7. PubMed ID: 18406224
    [No Abstract]   [Full Text] [Related]  

  • 24. Focus on: physical exercise in hemodialysis patients.
    Tentori F
    J Nephrol; 2008; 21(6):808-12. PubMed ID: 19034864
    [No Abstract]   [Full Text] [Related]  

  • 25. [Renal insufficiency is an important cardiovascular risk factor].
    Pérez Flores I; Luño J
    Nefrologia; 2002; 22(4):306-9. PubMed ID: 12369120
    [No Abstract]   [Full Text] [Related]  

  • 26. Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States.
    Collins AJ; Kasiske B; Herzog C; Chen SC; Everson S; Constantini E; Grimm R; McBean M; Xue J; Chavers B; Matas A; Manning W; Louis T; Pan W; Liu J; Li S; Roberts T; Dalleska F; Snyder J; Ebben J; Frazier E; Sheets D; Johnson R; Li S; Dunning S; Berrini D; Guo H; Solid C; Arko C; Daniels F; Wang X; Forrest B; Gilbertson D; St Peter W; Frederick P; Eggers P; Agodoa L
    Am J Kidney Dis; 2003 Dec; 42(6 Suppl 5):A5-7, S1-230. PubMed ID: 14655179
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiovascular risk factors in chronic renal failure and hemodialysis populations.
    Ma KW; Greene EL; Raij L
    Am J Kidney Dis; 1992 Jun; 19(6):505-13. PubMed ID: 1534442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of cardiovascular disease in patients on thrice-weekly versus twice-weekly hemodialysis.
    Cheng Y; Tu W; Xiao Q; Chen Y; Hu L; Wu X
    Int J Cardiol; 2014 Jul; 174(3):780-3. PubMed ID: 24768378
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic kidney disease: common, harmful, and treatable--World Kidney Day 2007.
    Levey AS; Andreoli SP; DuBose T; Provenzano R; Collins AJ
    J Am Soc Nephrol; 2007 Feb; 18(2):374-8. PubMed ID: 17229914
    [No Abstract]   [Full Text] [Related]  

  • 30. [Morbidity in hemodialysis].
    Galindo P; Martínez Sánchez T; Osuna A; Asensio C
    Nefrologia; 2002; 22(2):202-3. PubMed ID: 12085423
    [No Abstract]   [Full Text] [Related]  

  • 31. Morbidity and mortality on maintenance haemodialysis.
    Locatelli F; Del Vecchio L; Manzoni C
    Contrib Nephrol; 1998; 124():166-89; discussion 190-201. PubMed ID: 9761980
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiovascular abnormalities in children on long-term dialysis: analysis of risk factors.
    Quek CM; Foong PP; Liew CW; Lim YC; Heng CK; Lau YW; Yap HK
    Ann Acad Med Singap; 2004 Sep; 33(5 Suppl):S81-2. PubMed ID: 15651224
    [No Abstract]   [Full Text] [Related]  

  • 33. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk factors of cardiovascular diseases and chronic renal failure].
    Belialov FI
    Kardiologiia; 2005; 45(7):92-6. PubMed ID: 16091672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in end-stage renal disease. Epidemiology, morbidity, and mortality.
    Reikes ST
    Postgrad Med; 2000 Jul; 108(1):124-6, 129-31, 135-6 passim. PubMed ID: 10914123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States.
    Collins AJ; Kasiske B; Herzog C; Chavers B; Foley R; Gilbertson D; Grimm R; Liu J; Louis T; Manning W; Matas A; McBean M; Murray A; St Peter W; Xue J; Fan Q; Guo H; Li S; Li S; Roberts T; Snyder J; Solid C; Wang C; Weinhandl E; Arko C; Chen SC; Dalleska F; Daniels F; Dunning S; Ebben J; Frazier E; Johnson R; Sheets D; Forrest B; Berrini D; Constantini E; Everson S; Frederick P; Eggers P; Agodoa L;
    Am J Kidney Dis; 2005 Jan; 45(1 Suppl 1):A5-7, S1-280. PubMed ID: 15640975
    [No Abstract]   [Full Text] [Related]  

  • 37. Interventions for other risk factors: tobacco use, physical inactivity, menopause, and homocysteine.
    Beto JA; Bansal VK
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S172-83. PubMed ID: 9820474
    [No Abstract]   [Full Text] [Related]  

  • 38. Do potassium deficient diets and K+ removal by dialysis contribute to the cardiovascular morbidity and mortality of patients with end stage renal disease?
    Dolson GM
    Int J Artif Organs; 1997 Mar; 20(3):134-5. PubMed ID: 9151147
    [No Abstract]   [Full Text] [Related]  

  • 39. Are antihypertensive drugs used to maximally reduce cardiovascular risk in dialysis patients?
    Garg J; Bakris GL
    Am J Kidney Dis; 2003 Dec; 42(6):1301-4. PubMed ID: 14655205
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular disease in chronic renal failure. Risk factors and prevention.
    Henriquez D; Dikow R; Ritz E
    Nefrologia; 2004; 24 Suppl 4():34-9. PubMed ID: 15279384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.